UIPATH INC - CLASS A (PATH) Fundamental Analysis & Valuation

NYSE:PATH • US90364P1057

Current stock price

10.56 USD
+0.15 (+1.44%)
At close:
10.65 USD
+0.09 (+0.85%)
Pre-Market:

This PATH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. PATH Profitability Analysis

1.1 Basic Checks

  • PATH had positive earnings in the past year.
  • In the past year PATH had a positive cash flow from operations.
  • In the past 5 years PATH reported 4 times negative net income.
  • In multiple years PATH reported negative operating cash flow during the last 5 years.
PATH Yearly Net Income VS EBIT VS OCF VS FCFPATH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 2026 0 200M -200M -400M

1.2 Ratios

  • The Return On Assets of PATH (8.88%) is better than 84.56% of its industry peers.
  • Looking at the Return On Equity, with a value of 13.56%, PATH is in the better half of the industry, outperforming 78.68% of the companies in the same industry.
  • The Return On Invested Capital of PATH (2.13%) is better than 65.81% of its industry peers.
Industry RankSector Rank
ROA 8.88%
ROE 13.56%
ROIC 2.13%
ROA(3y)1.09%
ROA(5y)-5.83%
ROE(3y)1.7%
ROE(5y)-7.87%
ROIC(3y)N/A
ROIC(5y)N/A
PATH Yearly ROA, ROE, ROICPATH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2026 0 -50 -100 -150 -200 -250

1.3 Margins

  • The Profit Margin of PATH (17.53%) is better than 83.46% of its industry peers.
  • With a decent Operating Margin value of 3.80%, PATH is doing good in the industry, outperforming 65.81% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 83.21%, PATH belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
  • In the last couple of years the Gross Margin of PATH has remained more or less at the same level.
Industry RankSector Rank
OM 3.8%
PM (TTM) 17.53%
GM 83.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y-1.37%
PATH Yearly Profit, Operating, Gross MarginsPATH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 2026 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. PATH Health Analysis

2.1 Basic Checks

  • PATH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for PATH has been reduced compared to 1 year ago.
  • Compared to 5 years ago, PATH has more shares outstanding
  • PATH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PATH Yearly Shares OutstandingPATH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
PATH Yearly Total Debt VS Total AssetsPATH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 3.35 indicates that PATH is not in any danger for bankruptcy at the moment.
  • PATH has a better Altman-Z score (3.35) than 66.54% of its industry peers.
  • There is no outstanding debt for PATH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.35
ROIC/WACC0.2
WACC10.59%
PATH Yearly LT Debt VS Equity VS FCFPATH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 2026 0 500M 1B 1.5B 2B

2.3 Liquidity

  • PATH has a Current Ratio of 2.48. This indicates that PATH is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.48, PATH is doing good in the industry, outperforming 67.65% of the companies in the same industry.
  • PATH has a Quick Ratio of 2.48. This indicates that PATH is financially healthy and has no problem in meeting its short term obligations.
  • PATH's Quick ratio of 2.48 is fine compared to the rest of the industry. PATH outperforms 68.38% of its industry peers.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 2.48
PATH Yearly Current Assets VS Current LiabilitesPATH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. PATH Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 33.33% over the past year.
  • The Earnings Per Share has been growing by 68.69% on average over the past years. This is a very strong growth
  • Looking at the last year, PATH shows a quite strong growth in Revenue. The Revenue has grown by 12.65% in the last year.
  • PATH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.53% yearly.
EPS 1Y (TTM)33.33%
EPS 3Y68.69%
EPS 5YN/A
EPS Q2Q%15.38%
Revenue 1Y (TTM)12.65%
Revenue growth 3Y15.01%
Revenue growth 5Y21.53%
Sales Q2Q%13.56%

3.2 Future

  • Based on estimates for the next years, PATH will show a decrease in Earnings Per Share. The EPS will decrease by -1.64% on average per year.
  • PATH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.52% yearly.
EPS Next Y14.23%
EPS Next 2Y13.15%
EPS Next 3Y12.5%
EPS Next 5Y-1.64%
Revenue Next Year10.83%
Revenue Next 2Y9.66%
Revenue Next 3Y9.04%
Revenue Next 5Y10.52%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
PATH Yearly Revenue VS EstimatesPATH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
PATH Yearly EPS VS EstimatesPATH Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6 0.8 1

More info and screens

Find the best growth stocksShow best growing peers

6

4. PATH Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.67 indicates a correct valuation of PATH.
  • 81.99% of the companies in the same industry are more expensive than PATH, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.95. PATH is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 12.84, which indicates a correct valuation of PATH.
  • Based on the Price/Forward Earnings ratio, PATH is valued a bit cheaper than the industry average as 79.78% of the companies are valued more expensively.
  • PATH is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.67
Fwd PE 12.84
PATH Price Earnings VS Forward Price EarningsPATH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • PATH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PATH is cheaper than 60.29% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, PATH is valued cheaply inside the industry as 80.88% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 15.71
EV/EBITDA 44.27
PATH Per share dataPATH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • PATH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • PATH's earnings are expected to grow with 12.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.03
PEG (5Y)N/A
EPS Next 2Y13.15%
EPS Next 3Y12.5%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PATH Dividend Analysis

5.1 Amount

  • No dividends for PATH!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PATH Fundamentals: All Metrics, Ratios and Statistics

UIPATH INC - CLASS A

NYSE:PATH (4/20/2026, 8:24:22 PM)

Premarket: 10.65 +0.09 (+0.85%)

10.56

+0.15 (+1.44%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-11
Earnings (Next)05-27
Inst Owners80.26%
Inst Owner Change-0.27%
Ins Owners9.37%
Ins Owner Change-1.33%
Market Cap5.53B
Revenue(TTM)1.61B
Net Income(TTM)282.33M
Analysts67.86
Price Target14.06 (33.14%)
Short Float %22.49%
Short Ratio2.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.46%
Min EPS beat(2)7.4%
Max EPS beat(2)15.53%
EPS beat(4)4
Avg EPS beat(4)28.49%
Min EPS beat(4)7.36%
Max EPS beat(4)83.69%
EPS beat(8)8
Avg EPS beat(8)27.32%
EPS beat(12)12
Avg EPS beat(12)71.21%
EPS beat(16)16
Avg EPS beat(16)86.55%
Revenue beat(2)2
Avg Revenue beat(2)2.06%
Min Revenue beat(2)1.55%
Max Revenue beat(2)2.57%
Revenue beat(4)4
Avg Revenue beat(4)2.81%
Min Revenue beat(4)1.55%
Max Revenue beat(4)5.03%
Revenue beat(8)6
Avg Revenue beat(8)1.21%
Revenue beat(12)9
Avg Revenue beat(12)1.58%
Revenue beat(16)13
Avg Revenue beat(16)2.55%
PT rev (1m)-14.73%
PT rev (3m)-16.07%
EPS NQ rev (1m)-0.99%
EPS NQ rev (3m)4.32%
EPS NY rev (1m)5.75%
EPS NY rev (3m)6.48%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)1.26%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)1.24%
Valuation
Industry RankSector Rank
PE 14.67
Fwd PE 12.84
P/S 3.44
P/FCF 15.71
P/OCF 14.9
P/B 2.66
P/tB 2.86
EV/EBITDA 44.27
EPS(TTM)0.72
EY6.82%
EPS(NY)0.82
Fwd EY7.79%
FCF(TTM)0.67
FCFY6.37%
OCF(TTM)0.71
OCFY6.71%
SpS3.07
BVpS3.98
TBVpS3.7
PEG (NY)1.03
PEG (5Y)N/A
Graham Number8.02466 (-24.01%)
Profitability
Industry RankSector Rank
ROA 8.88%
ROE 13.56%
ROCE 2.69%
ROIC 2.13%
ROICexc 6.03%
ROICexgc 7.37%
OM 3.8%
PM (TTM) 17.53%
GM 83.21%
FCFM 21.87%
ROA(3y)1.09%
ROA(5y)-5.83%
ROE(3y)1.7%
ROE(5y)-7.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y-1.37%
F-Score8
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 112.25%
Cap/Sales 1.18%
Interest Coverage 250
Cash Conversion 475.08%
Profit Quality 124.73%
Current Ratio 2.48
Quick Ratio 2.48
Altman-Z 3.35
F-Score8
WACC10.59%
ROIC/WACC0.2
Cap/Depr(3y)77.11%
Cap/Depr(5y)89.47%
Cap/Sales(3y)0.93%
Cap/Sales(5y)1.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3Y68.69%
EPS 5YN/A
EPS Q2Q%15.38%
EPS Next Y14.23%
EPS Next 2Y13.15%
EPS Next 3Y12.5%
EPS Next 5Y-1.64%
Revenue 1Y (TTM)12.65%
Revenue growth 3Y15.01%
Revenue growth 5Y21.53%
Sales Q2Q%13.56%
Revenue Next Year10.83%
Revenue Next 2Y9.66%
Revenue Next 3Y9.04%
Revenue Next 5Y10.52%
EBIT growth 1Y144.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.76%
EBIT Next 3Y17.5%
EBIT Next 5Y12.97%
FCF growth 1Y15.22%
FCF growth 3YN/A
FCF growth 5Y68.42%
OCF growth 1Y15.8%
OCF growth 3YN/A
OCF growth 5Y66.31%

UIPATH INC - CLASS A / PATH Fundamental Analysis FAQ

What is the fundamental rating for PATH stock?

ChartMill assigns a fundamental rating of 6 / 10 to PATH.


What is the valuation status for PATH stock?

ChartMill assigns a valuation rating of 6 / 10 to UIPATH INC - CLASS A (PATH). This can be considered as Fairly Valued.


Can you provide the profitability details for UIPATH INC - CLASS A?

UIPATH INC - CLASS A (PATH) has a profitability rating of 5 / 10.


What is the valuation of UIPATH INC - CLASS A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for UIPATH INC - CLASS A (PATH) is 14.67 and the Price/Book (PB) ratio is 2.66.